FindTrial
Sign In

Clinical application of type I collagen tissue engineering scaffold in orbital wall repair

Clinical application of type I collagen tissue engineering scaffold in orbital wall repair

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013722
Enrollment
Unknown
Registered
2017-12-06
Start date
2017-12-15
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orbital wall repair of sinonasal malignant tumor

Interventions

treatment group:titanium product joint type I collagen tissue engineering scaffold
control group:titanium product joint gelatin sponge

Sponsors

Beijing TongRen Hospital, Capital Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. orbital wall defect in sinonasal tumor; 2. Blood routine examination, main organs such as heart, lung, liver and kidney function is almost normal; 3. treatment may bring benefits

Exclusion criteria

Exclusion criteria: 1. Primary ocular diseases; 2. previous history of surgery or radiotherapy; 3. allergy to titanium products or collagen tissue; 4. The ones who researchers did not consider the case of the appropriate group

Design outcomes

Primary

MeasureTime frame
facial appearance and eyefunction (eye movement and Hess screen);—

Countries

China

Contacts

Public ContactXiaohong Chen

Beijing TongRen Hospital, Capital Medicine University

trchxh@163.com+86 13911071002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026